Study
|
eGFR
(Mean±SD)
|
eGFR
(Mean±SD)
|
eGFR
>/= 60
ml/min/1.73 m2
NO. (%)
|
eGFR
>/= 60
ml/min/1.73 m2
NO. (%)
|
eGFR
45 to < 60
ml/min/1.73
m2 NO. (%)
|
eGFR
45 to < 60
ml/min/1.73
m2 NO. (%)
|
eGFR \
25 to < 45
ml/min/1.73 m2
NO. (%)
|
eGFR \
25 to < 45
ml/min/1.73 m2
NO. (%)
|
eGFR
< 25 ml/min/1.73
m2
NO. (%)
|
eGFR
< 25 ml/min/1.73
m2
NO. (%)
|
urinary albumin
to creatinine ratio
(Mean±SD)
|
urinary albumin
to creatinine ratio
(Mean±SD)
|
UACR< 30
NO. (%)
|
UACR< 30
NO. (%)
|
UACR 30 to< 300
NO. (%)
|
UACR 30 to< 300
NO. (%)
|
UACR >/= 300
NO. (%)
|
UACR >/= 300
NO. (%)
|
|
Fineren
one
|
Placeb
o
|
Fineren
one
|
Placebo
|
Fineren
one
|
Placebo
|
Fineren
one
|
Placebo
|
Fineren
one
|
Placebo
|
Fineren
one
|
Placebo
|
Fineren
one
|
Placebo
|
Fineren
one
|
Placebo
|
Fineren
one
|
Placebo
|
Bakris (2015)[13]
|
66.9±
21.8
|
72.2±
20.4
|
N/A
|
N/A
|
302
(41.5)
|
26
(27.7)
|
N/A
|
N/A
|
N/A
|
N/A
|
190±649.5
|
182.9±563
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
Katayama (2017)[17]
|
65.2± 13.7 |
60.8± 16.5 |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
217.6± 221.4 |
256.8±
166.3 |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Bakris
(2020)[14]
|
44.4±
12.5
|
44.3±
12.6
|
318 (11.2)
|
338 (11.9)
|
972 (34.3)
|
928 (32.7)
|
1476 (52.1)
|
1505 (53.0)
|
66 (2.3)
|
69 (2.4)
|
833± 219.8
|
867± 220.7
|
11 (0.4)
|
12 (0.4)
|
350 (12.4)
|
335 (11.8)
|
2470 (87.2)
|
2493 (87.8)
|
Bertram
(2021)[10]
|
67.6±
21.7
|
68.0±
21.7
|
2285 (62.0)
|
2254 (61.5)
|
745 (20.2)
|
789 (21.5)
|
641 (17.4)
|
610 (16.6)
|
15 (0.4)
|
12 (0.3)
|
302± 119.2
|
315± 114.8
|
109 (3.0)
|
98 (2.7)
|
1726 (46.8)
|
1688 (46.0)
|
1851 (50.2)
|
1878 (51.2)
|
Gerasimos
(2021)[15]
|
44.3±
12.5
|
44.3±
12.5
|
318
(11.2)
|
338
(11.8)
|
972
(34.3)
|
928
(32.6)
|
1476
(52.1)
|
1505
(52.9)
|
66
(2.3)
|
69
(2.4)
|
831± 146.5
|
867.5± 221.7
|
11
(0.3)
|
12
(0.4)
|
350
(12.3)
|
335
(11.7)
|
2470
(87.1)
|
2493
(87.7)
|
Agarwal
(2022)[5]
|
57.5 ± 21.6
|
57.7 ± 21.8
|
2603 (39.9)
|
2592 (39.8)
|
1717 (26.3)
|
1717 (26.4)
|
2117 (32.5)
|
2115 (32.5)
|
81 (1.2)
|
81 (1.2)
|
514± 172.42
|
515± 178.7
|
120 (1.8)
|
110 (1.7)
|
2076 (31.8)
|
2023 (31.1)
|
4321 (66.3)
|
4371 (67.2)
|
Gerasimos
(2022)[16]
|
65.95± 21.5
|
65.61± 21.83
|
2285
(61.9)
|
2354
(64.2)
|
745
(20.2)
|
789
(21.5)
|
641
(17.3)
|
610
(16.6)
|
15
(0.4)
|
12
(0.3)
|
289.4± 118.3
|
283.8± 116.8
|
109
(2.9)
|
98
(2.6)
|
1726
(46.8)
|
1688
(46)
|
1851
(50.2)
|
1878
(51.2)
|